These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

295 related items for PubMed ID: 14520387

  • 21. China pushes liver proteomics.
    Jia H, Louët S.
    Nat Biotechnol; 2004 Feb; 22(2):136. PubMed ID: 14755276
    [No Abstract] [Full Text] [Related]

  • 22. US government previews biotech survey.
    Goho A.
    Nat Biotechnol; 2003 Aug; 21(8):837-8. PubMed ID: 12894185
    [No Abstract] [Full Text] [Related]

  • 23. Nanotechnology: convergence with modern biology and medicine.
    Roco MC.
    Curr Opin Biotechnol; 2003 Jun; 14(3):337-46. PubMed ID: 12849790
    [Abstract] [Full Text] [Related]

  • 24. Brussels backs nanotech.
    Nat Nanotechnol; 2007 Feb; 2(2):65. PubMed ID: 18654212
    [No Abstract] [Full Text] [Related]

  • 25. Japanese council urges reform of funding system.
    Triendl R.
    Nat Biotechnol; 2002 Dec; 20(12):1176-8. PubMed ID: 12454656
    [No Abstract] [Full Text] [Related]

  • 26. Rainbow biotech--South Africa's emerging sector.
    Louët S.
    Nat Biotechnol; 2006 Nov; 24(11):1313-6. PubMed ID: 17093464
    [No Abstract] [Full Text] [Related]

  • 27. Evolving symbiosis--venture capital and biotechnology.
    Bradford TC.
    Nat Biotechnol; 2003 Sep; 21(9):983-4. PubMed ID: 12949556
    [No Abstract] [Full Text] [Related]

  • 28. Translational science: a view from a biotechnology investor.
    Klausner R.
    Sci Transl Med; 2010 Jun 02; 2(34):34ed3. PubMed ID: 20519715
    [No Abstract] [Full Text] [Related]

  • 29. Small world, big hopes.
    Watanabe M.
    Nat Mater; 2004 Jan 02; 3(1):73-4. PubMed ID: 14704788
    [No Abstract] [Full Text] [Related]

  • 30. The birth of nanoChina.
    Sandhu A.
    Nat Nanotechnol; 2007 Jan 02; 2(1):11-2. PubMed ID: 18654194
    [No Abstract] [Full Text] [Related]

  • 31. Granting you success.
    Beylin D, Chrisman CJ, Weingarten M.
    Nat Biotechnol; 2011 Jul 02; 29(7):567-70. PubMed ID: 21874663
    [No Abstract] [Full Text] [Related]

  • 32. Biotechs get $1 billion windfall in R&D tax credits.
    Thiel K.
    Nat Biotechnol; 2009 Dec 02; 27(12):1066. PubMed ID: 20010563
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Biotechnology financing dilemmas and the role of special purpose entities.
    Schiff L, Murray F.
    Nat Biotechnol; 2004 Mar 02; 22(3):271-7. PubMed ID: 14990945
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Investors likely to venture back as crisis subsides.
    Glick JL.
    Nature; 2009 Aug 27; 460(7259):1079. PubMed ID: 19713912
    [No Abstract] [Full Text] [Related]

  • 37. The perils of subsidiarity.
    Nat Biotechnol; 2004 Dec 27; 22(12):1483. PubMed ID: 15583638
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Superscience me!
    Nat Biotechnol; 2007 Jun 27; 25(6):604. PubMed ID: 17557082
    [No Abstract] [Full Text] [Related]

  • 40. New biotech oasis?
    Sheridan C.
    Nat Biotechnol; 2005 Aug 27; 23(8):919. PubMed ID: 16114121
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.